Out of all the brain chemistry that Autism Spectrum Disorders researchers study, few molecules have received as much attention as the ‘social hormone,’ oxytocin. Some autistic children seem to have low levels of oxytocin in the blood, which has led to several trials to deliver oxytocin intranasally as an autism therapy. Until now, though, such trials have produced inconsistent results. In this article, we explain what scientists know about oxytocin’s connection to autism so far.
What does oxytocin do in the body and brain?
Oxytocin performs multiple functions in the brain and body, such as creating relationships of love and trust between us, preparing us for threatening situations, and supporting mother-child bonding and lactation. The hormone is primarily produced in the hypothalamus, a brain region that intercedes essential bodily functions, such as thirst, hunger, and body temperature. Oxytocin-producing neurons in the hypothalamus extend to the other parts of the brain, like the nucleus accumbens. Here, the hormone regulates social-reward learning.
In the brain’s sensory parts, such as the olfactory bulb, oxytocin appears to balance inhibitory and excitatory signals, hence improving social-information processing. Amygdala fosters social recognition and controls responses to threatening situations. In the pituitary gland, the release of oxytocin into the bloodstream is controlled, which is important for triggering uterine muscle contractions during childbirth. Furthermore, it also supports lactation by facilitating the milk letdown reflex and hence stimulating the milk flow into the nipple.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the oxytocin market include Pfizer, Novartis, GSK, JHP Pharmaceuticals, Grindeks, Jishi, Shanghai Hefeng, Bimeda, and Bayer.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Oxytocin Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/oxytocin-market/download-sampleMarket DynamicsGrowing demand for oxytocin owing to increasing childbirth with higher prevalence of complications during the pregnancy and childbirth is driving the market growth.
Increasing count of cases with induced breast milk production is another factor fueling the growth of this market.
Higher adoption of high quality assured drugs to prevent postpartum hemorrhage (PPH) is boosting the demand for oxytocin market.
However, high cost associated with the oxytocin is expected to hinder the market growth.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
